C-MER MEDICAL Cuts Outstanding Shares by 2.74 Million in July, Affirms Public-Float Compliance

Bulletin Express08-03

For the month ended 31 July 2026, C-MER Medical Holdings Limited reported a reduction of 2.74 million ordinary shares, bringing total issued share capital (excluding treasury shares) down to 1.21 billion. Concurrently, treasury shares rose to 23.36 million, while the overall issued share count remained unchanged at 1.23 billion.

Authorised capital was steady at 8.00 billion ordinary shares with a par value of HKD 0.10 each, maintaining total authorised capital at HKD 800 million.

The 2.74 million shares were repurchased on 20 May 2026 and are now held in treasury, accounting for the shift between issued and treasury shares during July.

Under the Post-IPO Share Option Scheme, 0.13 million options were outstanding at month-end; no options were exercised, and no new shares were issued or transferred from treasury. The scheme still allows for up to 92.12 million shares to be issued upon full exercise of all options that may be granted.

C-MER Medical confirmed that its public float comfortably meets the Main Board’s minimum 25% threshold as at 31 July 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1137823925?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-03 09:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1137823925","market":"us","top_or_hot":-1,"title":"C-MER MEDICAL Cuts Outstanding Shares by 2.74 Million in July, Affirms Public-Float Compliance","media":"Bulletin Express","content":"<p>For the month ended 31 July 2026, C-MER Medical Holdings Limited reported a reduction of 2.74 million ordinary shares, bringing total issued share capital (excluding treasury shares) down to 1.21 billion. Concurrently, treasury shares rose to 23.36 million, while the overall issued share count remained unchanged at 1.23 billion.</p>\n<p>Authorised capital was steady at 8.00 billion ordinary shares with a par value of HKD 0.10 each, maintaining total authorised capital at HKD 800 million.</p>\n<p>The 2.74 million shares were repurchased on 20 May 2026 and are now held in treasury, accounting for the shift between issued and treasury shares during July.</p>\n<p>Under the Post-IPO Share Option Scheme, 0.13 million options were outstanding at month-end; no options were exercised, and no new shares were issued or transferred from treasury. The scheme still allows for up to 92.12 million shares to be issued upon full exercise of all options that may be granted.</p>\n<p>C-MER Medical confirmed that its public float comfortably meets the Main Board’s minimum 25% threshold as at 31 July 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>C-MER MEDICAL Cuts Outstanding Shares by 2.74 Million in July, Affirms Public-Float Compliance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nC-MER MEDICAL Cuts Outstanding Shares by 2.74 Million in July, Affirms Public-Float Compliance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-03 09:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>For the month ended 31 July 2026, C-MER Medical Holdings Limited reported a reduction of 2.74 million ordinary shares, bringing total issued share capital (excluding treasury shares) down to 1.21 billion. Concurrently, treasury shares rose to 23.36 million, while the overall issued share count remained unchanged at 1.23 billion.</p>\n<p>Authorised capital was steady at 8.00 billion ordinary shares with a par value of HKD 0.10 each, maintaining total authorised capital at HKD 800 million.</p>\n<p>The 2.74 million shares were repurchased on 20 May 2026 and are now held in treasury, accounting for the shift between issued and treasury shares during July.</p>\n<p>Under the Post-IPO Share Option Scheme, 0.13 million options were outstanding at month-end; no options were exercised, and no new shares were issued or transferred from treasury. The scheme still allows for up to 92.12 million shares to be issued upon full exercise of all options that may be granted.</p>\n<p>C-MER Medical confirmed that its public float comfortably meets the Main Board’s minimum 25% threshold as at 31 July 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03309","symbol_name":"希玛医疗","start_time":0,"source_url":"","article_id":"1137823925","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1137823925","pubTimestamp":1785719058,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"For the month ended 31 July 2026, C-MER Medical Holdings Limited reported a reduction of 2.74 million ordinary shares, bringing total issued share capital (excluding treasury shares) down to 1.21...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03309":"希玛医疗"},"translate_title":"C-MER MEDICAL 7 月份削减流通股 274 万股，确认符合公开发行要求","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03309":1},"content_text":"For the month ended 31 July 2026, C-MER Medical Holdings Limited reported a reduction of 2.74 million ordinary shares, bringing total issued share capital (excluding treasury shares) down to 1.21 billion. Concurrently, treasury shares rose to 23.36 million, while the overall issued share count remained unchanged at 1.23 billion.\nAuthorised capital was steady at 8.00 billion ordinary shares with a par value of HKD 0.10 each, maintaining total authorised capital at HKD 800 million.\nThe 2.74 million shares were repurchased on 20 May 2026 and are now held in treasury, accounting for the shift between issued and treasury shares during July.\nUnder the Post-IPO Share Option Scheme, 0.13 million options were outstanding at month-end; no options were exercised, and no new shares were issued or transferred from treasury. The scheme still allows for up to 92.12 million shares to be issued upon full exercise of all options that may be granted.\nC-MER Medical confirmed that its public float comfortably meets the Main Board’s minimum 25% threshold as at 31 July 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1137823925","isCrawlerRequest":true}